Saudi Arabia Point Of Care Infectious Disease Diagnostics Testing Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030
Description
Saudi Arabia Point of Care Infectious Disease Diagnostics Testing
Market Overview
The Saudi Arabia Point of Care Infectious Disease Diagnostics Testing Market is valued at USD 180 million, based on a five-year historical analysis of point-of-care molecular diagnostics, rapid tests, and related infectious disease applications within the broader in vitro diagnostics landscape. This growth is primarily driven by the increasing prevalence of infectious diseases, the rising demand for rapid diagnostic solutions at or near the patient site, and advancements in molecular and lateral?flow technologies that enhance testing accuracy, connectivity, and turnaround time. Key cities such as Riyadh, Jeddah, and Dammam dominate the market due to their advanced healthcare infrastructure, high population density, and significant investments in tertiary and quaternary care facilities under Vision 2030. These urban centers host leading institutions like King Faisal Specialist Hospital and Research Centre and major private hospital groups, making them focal points for medical research, digital health pilots, and deployment of point-of-care platforms across emergency departments, outpatient clinics, and critical care units. Regulatory oversight of point-of-care infectious disease diagnostics is anchored by the Medical Devices Interim Regulation, issued by the Saudi Food and Drug Authority (SFDA) in 2013, which classifies in vitro diagnostic medical devices (including rapid tests and point-of-care analyzers) and stipulates requirements for pre?market approval, conformity assessment, post?market surveillance, and quality management systems for all devices used in public and private health facilities. Under this framework, SFDA has fast?tracked approvals for infectious disease POC assays to support national programs on respiratory infections, hepatitis, HIV, and other communicable diseases, strengthening adoption in hospitals, primary care centers, and community settings.
Saudi Arabia Point of Care Infectious Disease Diagnostics Testing
Market Segmentation
By Product & Kit Type: The product and kit type segmentation includes various diagnostic tools essential for point-of-care testing. The subsegments are as follows:
The Rapid Antigen Test Kits segment is currently dominating the market due to their ease of use, quick results, and cost-effectiveness, making them highly preferred in both clinical and near?patient community settings such as pharmacies and screening camps. The COVID?19 pandemic significantly boosted the demand for these kits, leading to widespread adoption for respiratory infection screening and occupational health programs. Additionally, the growing awareness of infectious diseases, expansion of respiratory, influenza, and flu?like illness testing, and the need for rapid diagnosis in emergency and primary care situations have further solidified their market position. As a result, this segment is expected to maintain its leadership in the coming years, while molecular POC cartridges and multiplex panels gain share in high?acuity and complex infection settings.
Saudi Arabia Point of Care Infectious Disease Diagnostics Testing
Market Segmentation
By End-User: The end-user segmentation highlights the various healthcare settings utilizing point-of-care testing. The subsegments are as follows:
Public Hospitals, particularly those under the Ministry of Health, are the leading end-users of point-of-care testing solutions, reflecting their role as high?volume hubs for emergency and inpatient care. This dominance is attributed to the high patient volume, growing burden of respiratory and other infectious diseases, and the urgent need for rapid diagnostic capabilities to support antimicrobial stewardship and isolation decisions. The integration of point-of-care testing into routine clinical workflows has been accelerated by Vision 2030 healthcare transformation initiatives, which promote decentralization of diagnostics, digital connectivity of devices, and improved access in emergency, critical care, and primary healthcare settings. Additionally, the increasing focus on patient-centered care, expansion of virtual care and telehealth programs, and the need for timely diagnosis in remote and out?of?hospital environments further enhance the role of public hospitals while driving uptake in pharmacies, primary care centers, and home/self?testing channels.
Saudi Arabia Point of Care Infectious Disease Diagnostics Testing Market
Competitive Landscape
The Saudi Arabia Point of Care Infectious Disease Diagnostics Testing Market is characterized by a dynamic mix of regional and international players. Leading participants such as Abbott Laboratories (Abbott Rapid Diagnostics, i?STAT), Roche Diagnostics (cobas Liat, Accu?Chek), Siemens Healthineers (epoc, RAPIDPoint), Becton, Dickinson and Company (BD Veritor, BD MAX POC), QuidelOrtho Corporation (QuickVue, Sofia), Cepheid (GeneXpert & Xpert Xpress Assays), bioMérieux (BIOFIRE FilmArray, VIKIA, VIDAS POC), Thermo Fisher Scientific (POC Molecular & Rapid Test Portfolio), Danaher Corporation – Beckman Coulter / Cepheid Group, Nova Biomedical (Nova StatStrip & POC Analyzers), SD Biosensor, Inc. (STANDARD Q & STANDARD F Rapid Tests), Bio-Rad Laboratories (POC Infectious Disease Controls & Kits), Trivitron Healthcare (POC Infectious Disease & Rapid Test Kits), Mylab Discovery Solutions Pvt. Ltd., DnaNudge Ltd., Al Borg Diagnostics (Regional Reference Lab & POC Deployment Partner), National Unified Procurement Company (NUPCO) – Centralized Procurement Body contribute to innovation, geographic expansion, and service delivery in this space.
Abbott Laboratories
1888 Chicago, Illinois, USA
Roche Diagnostics
1896 Basel, Switzerland
Siemens Healthineers
1847 Munich, Germany
Becton, Dickinson and Company 1897 Franklin Lakes, New Jersey, USA
QuidelOrtho Corporation
2022 San Diego, California, USA
Company
Establishment Year
Headquarters
Group Size (Global Multinational, Regional, or Local)
Saudi Arabia POC Infectious Disease Revenue (US$)
Revenue CAGR in Saudi Arabia POC Segment
Installed POC Analyzers / Platforms in Saudi Arabia
Number of Infectious Disease POC Assays in Portfolio
Share of Government & Institutional Sales (%)
Saudi Arabia Point of Care Infectious Disease Diagnostics Testing Market Industry Analysis
Growth Drivers
Increasing Prevalence of Infectious Diseases: The rise in infectious diseases in Saudi Arabia is significant, with the Ministry of Health reporting over 1.5 million cases of communicable diseases in the current year. This alarming trend necessitates rapid diagnostic solutions, driving demand for point-of-care testing. The World Health Organization indicates that the prevalence of diseases like tuberculosis and hepatitis is increasing, further emphasizing the need for effective diagnostic tools to manage public health effectively. Rising Demand for Rapid Diagnostic Solutions: The urgency for quick diagnostic results is evident, with a reported 60% increase in demand for rapid testing solutions in the previous year. Healthcare facilities are prioritizing point-of-care diagnostics to reduce patient wait times and improve treatment outcomes. The Saudi government aims to enhance healthcare delivery, which aligns with the growing preference for immediate testing solutions, thereby propelling market growth in this sector. Government Initiatives to Enhance Healthcare Infrastructure: The Saudi Vision 2030 initiative allocates approximately $40 billion to improve healthcare infrastructure, including diagnostic services. This investment aims to modernize healthcare facilities and expand access to point-of-care testing. The government’s commitment to enhancing healthcare services is expected to significantly boost the adoption of innovative diagnostic technologies, thereby fostering market growth in the point-of-care infectious disease diagnostics sector.
Market Challenges
High Costs of Advanced Diagnostic Equipment: The initial investment required for advanced point-of-care diagnostic equipment can exceed $100,000, posing a significant barrier for many healthcare providers. This high cost limits accessibility, particularly in rural areas where budgets are constrained. As a result, many facilities may opt for traditional laboratory testing, which can delay diagnosis and treatment, hindering the overall growth of the market. Limited Awareness Among Healthcare Providers: Despite the benefits of point-of-care testing, many healthcare providers remain unaware of the latest technologies. A survey indicated that over 40% of healthcare professionals in Saudi Arabia lack knowledge about the advantages of rapid diagnostic solutions. This gap in awareness can lead to underutilization of available technologies, ultimately stalling market growth and limiting patient access to timely diagnostics.
Saudi Arabia Point of Care Infectious Disease Diagnostics Testing Market
Future Outlook
The future of the Saudi Arabia point of care infectious disease diagnostics testing market appears promising, driven by technological advancements and increasing healthcare investments. The integration of artificial intelligence in diagnostic processes is expected to enhance accuracy and efficiency. Additionally, the expansion of telemedicine and remote diagnostics will likely facilitate greater access to testing, particularly in underserved areas, thereby improving overall healthcare delivery and patient outcomes in the region.
Market Opportunities
Expansion of Telemedicine and Remote Diagnostics: The growing adoption of telemedicine, projected to reach a market value of $1.5 billion in the near future, presents a significant opportunity for point-of-care diagnostics. This trend allows for remote testing and consultations, improving access to healthcare services, especially in rural areas where traditional healthcare facilities are limited. Increasing Investment in Healthcare R&D: With the Saudi government investing over $1 billion in healthcare research and development in the near future, there is a substantial opportunity for innovation in diagnostic technologies. This funding can lead to the development of new point-of-care testing solutions, enhancing disease detection and management capabilities across the healthcare system.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
Market Overview
The Saudi Arabia Point of Care Infectious Disease Diagnostics Testing Market is valued at USD 180 million, based on a five-year historical analysis of point-of-care molecular diagnostics, rapid tests, and related infectious disease applications within the broader in vitro diagnostics landscape. This growth is primarily driven by the increasing prevalence of infectious diseases, the rising demand for rapid diagnostic solutions at or near the patient site, and advancements in molecular and lateral?flow technologies that enhance testing accuracy, connectivity, and turnaround time. Key cities such as Riyadh, Jeddah, and Dammam dominate the market due to their advanced healthcare infrastructure, high population density, and significant investments in tertiary and quaternary care facilities under Vision 2030. These urban centers host leading institutions like King Faisal Specialist Hospital and Research Centre and major private hospital groups, making them focal points for medical research, digital health pilots, and deployment of point-of-care platforms across emergency departments, outpatient clinics, and critical care units. Regulatory oversight of point-of-care infectious disease diagnostics is anchored by the Medical Devices Interim Regulation, issued by the Saudi Food and Drug Authority (SFDA) in 2013, which classifies in vitro diagnostic medical devices (including rapid tests and point-of-care analyzers) and stipulates requirements for pre?market approval, conformity assessment, post?market surveillance, and quality management systems for all devices used in public and private health facilities. Under this framework, SFDA has fast?tracked approvals for infectious disease POC assays to support national programs on respiratory infections, hepatitis, HIV, and other communicable diseases, strengthening adoption in hospitals, primary care centers, and community settings.
Saudi Arabia Point of Care Infectious Disease Diagnostics Testing
Market Segmentation
By Product & Kit Type: The product and kit type segmentation includes various diagnostic tools essential for point-of-care testing. The subsegments are as follows:
The Rapid Antigen Test Kits segment is currently dominating the market due to their ease of use, quick results, and cost-effectiveness, making them highly preferred in both clinical and near?patient community settings such as pharmacies and screening camps. The COVID?19 pandemic significantly boosted the demand for these kits, leading to widespread adoption for respiratory infection screening and occupational health programs. Additionally, the growing awareness of infectious diseases, expansion of respiratory, influenza, and flu?like illness testing, and the need for rapid diagnosis in emergency and primary care situations have further solidified their market position. As a result, this segment is expected to maintain its leadership in the coming years, while molecular POC cartridges and multiplex panels gain share in high?acuity and complex infection settings.
Saudi Arabia Point of Care Infectious Disease Diagnostics Testing
Market Segmentation
By End-User: The end-user segmentation highlights the various healthcare settings utilizing point-of-care testing. The subsegments are as follows:
Public Hospitals, particularly those under the Ministry of Health, are the leading end-users of point-of-care testing solutions, reflecting their role as high?volume hubs for emergency and inpatient care. This dominance is attributed to the high patient volume, growing burden of respiratory and other infectious diseases, and the urgent need for rapid diagnostic capabilities to support antimicrobial stewardship and isolation decisions. The integration of point-of-care testing into routine clinical workflows has been accelerated by Vision 2030 healthcare transformation initiatives, which promote decentralization of diagnostics, digital connectivity of devices, and improved access in emergency, critical care, and primary healthcare settings. Additionally, the increasing focus on patient-centered care, expansion of virtual care and telehealth programs, and the need for timely diagnosis in remote and out?of?hospital environments further enhance the role of public hospitals while driving uptake in pharmacies, primary care centers, and home/self?testing channels.
Saudi Arabia Point of Care Infectious Disease Diagnostics Testing Market
Competitive Landscape
The Saudi Arabia Point of Care Infectious Disease Diagnostics Testing Market is characterized by a dynamic mix of regional and international players. Leading participants such as Abbott Laboratories (Abbott Rapid Diagnostics, i?STAT), Roche Diagnostics (cobas Liat, Accu?Chek), Siemens Healthineers (epoc, RAPIDPoint), Becton, Dickinson and Company (BD Veritor, BD MAX POC), QuidelOrtho Corporation (QuickVue, Sofia), Cepheid (GeneXpert & Xpert Xpress Assays), bioMérieux (BIOFIRE FilmArray, VIKIA, VIDAS POC), Thermo Fisher Scientific (POC Molecular & Rapid Test Portfolio), Danaher Corporation – Beckman Coulter / Cepheid Group, Nova Biomedical (Nova StatStrip & POC Analyzers), SD Biosensor, Inc. (STANDARD Q & STANDARD F Rapid Tests), Bio-Rad Laboratories (POC Infectious Disease Controls & Kits), Trivitron Healthcare (POC Infectious Disease & Rapid Test Kits), Mylab Discovery Solutions Pvt. Ltd., DnaNudge Ltd., Al Borg Diagnostics (Regional Reference Lab & POC Deployment Partner), National Unified Procurement Company (NUPCO) – Centralized Procurement Body contribute to innovation, geographic expansion, and service delivery in this space.
Abbott Laboratories
1888 Chicago, Illinois, USA
Roche Diagnostics
1896 Basel, Switzerland
Siemens Healthineers
1847 Munich, Germany
Becton, Dickinson and Company 1897 Franklin Lakes, New Jersey, USA
QuidelOrtho Corporation
2022 San Diego, California, USA
Company
Establishment Year
Headquarters
Group Size (Global Multinational, Regional, or Local)
Saudi Arabia POC Infectious Disease Revenue (US$)
Revenue CAGR in Saudi Arabia POC Segment
Installed POC Analyzers / Platforms in Saudi Arabia
Number of Infectious Disease POC Assays in Portfolio
Share of Government & Institutional Sales (%)
Saudi Arabia Point of Care Infectious Disease Diagnostics Testing Market Industry Analysis
Growth Drivers
Increasing Prevalence of Infectious Diseases: The rise in infectious diseases in Saudi Arabia is significant, with the Ministry of Health reporting over 1.5 million cases of communicable diseases in the current year. This alarming trend necessitates rapid diagnostic solutions, driving demand for point-of-care testing. The World Health Organization indicates that the prevalence of diseases like tuberculosis and hepatitis is increasing, further emphasizing the need for effective diagnostic tools to manage public health effectively. Rising Demand for Rapid Diagnostic Solutions: The urgency for quick diagnostic results is evident, with a reported 60% increase in demand for rapid testing solutions in the previous year. Healthcare facilities are prioritizing point-of-care diagnostics to reduce patient wait times and improve treatment outcomes. The Saudi government aims to enhance healthcare delivery, which aligns with the growing preference for immediate testing solutions, thereby propelling market growth in this sector. Government Initiatives to Enhance Healthcare Infrastructure: The Saudi Vision 2030 initiative allocates approximately $40 billion to improve healthcare infrastructure, including diagnostic services. This investment aims to modernize healthcare facilities and expand access to point-of-care testing. The government’s commitment to enhancing healthcare services is expected to significantly boost the adoption of innovative diagnostic technologies, thereby fostering market growth in the point-of-care infectious disease diagnostics sector.
Market Challenges
High Costs of Advanced Diagnostic Equipment: The initial investment required for advanced point-of-care diagnostic equipment can exceed $100,000, posing a significant barrier for many healthcare providers. This high cost limits accessibility, particularly in rural areas where budgets are constrained. As a result, many facilities may opt for traditional laboratory testing, which can delay diagnosis and treatment, hindering the overall growth of the market. Limited Awareness Among Healthcare Providers: Despite the benefits of point-of-care testing, many healthcare providers remain unaware of the latest technologies. A survey indicated that over 40% of healthcare professionals in Saudi Arabia lack knowledge about the advantages of rapid diagnostic solutions. This gap in awareness can lead to underutilization of available technologies, ultimately stalling market growth and limiting patient access to timely diagnostics.
Saudi Arabia Point of Care Infectious Disease Diagnostics Testing Market
Future Outlook
The future of the Saudi Arabia point of care infectious disease diagnostics testing market appears promising, driven by technological advancements and increasing healthcare investments. The integration of artificial intelligence in diagnostic processes is expected to enhance accuracy and efficiency. Additionally, the expansion of telemedicine and remote diagnostics will likely facilitate greater access to testing, particularly in underserved areas, thereby improving overall healthcare delivery and patient outcomes in the region.
Market Opportunities
Expansion of Telemedicine and Remote Diagnostics: The growing adoption of telemedicine, projected to reach a market value of $1.5 billion in the near future, presents a significant opportunity for point-of-care diagnostics. This trend allows for remote testing and consultations, improving access to healthcare services, especially in rural areas where traditional healthcare facilities are limited. Increasing Investment in Healthcare R&D: With the Saudi government investing over $1 billion in healthcare research and development in the near future, there is a substantial opportunity for innovation in diagnostic technologies. This funding can lead to the development of new point-of-care testing solutions, enhancing disease detection and management capabilities across the healthcare system.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
Table of Contents
81 Pages
- 1. Saudi Arabia Point Of Care Infectious Disease Diagnostics Testing Size, Share, Growth Drivers, Trends, Opportunities & – Market Overview
- 1.1. Definition and Scope
- 1.2. Market Taxonomy
- 1.3. Market Growth Rate
- 1.4. Market Segmentation Overview
- 2. Saudi Arabia Point Of Care Infectious Disease Diagnostics Testing Size, Share, Growth Drivers, Trends, Opportunities & – Market Size (in USD Bn), 2019–2024
- 2.1. Historical Market Size
- 2.2. Year-on-Year Growth Analysis
- 2.3. Key Market Developments and Milestones
- 3. Saudi Arabia Point Of Care Infectious Disease Diagnostics Testing Size, Share, Growth Drivers, Trends, Opportunities & – Market Analysis
- 3.1. Growth Drivers
- 3.1.1. Increasing prevalence of infectious diseases in Saudi Arabia
- 3.1.2. Government initiatives for healthcare improvement
- 3.1.3. Advancements in diagnostic technologies
- 3.1.4. Rising demand for rapid testing solutions
- 3.2. Restraints
- 3.2.1. High costs associated with advanced diagnostic equipment
- 3.2.2. Limited awareness among healthcare providers
- 3.2.3. Regulatory challenges in product approvals
- 3.2.4. Competition from traditional laboratory testing
- 3.3. Opportunities
- 3.3.1. Expansion of healthcare infrastructure
- 3.3.2. Growing investment in research and development
- 3.3.3. Increasing partnerships between public and private sectors
- 3.3.4. Rising consumer awareness about health and wellness
- 3.4. Trends
- 3.4.1. Shift towards home-based testing solutions
- 3.4.2. Integration of AI and machine learning in diagnostics
- 3.4.3. Focus on personalized medicine
- 3.4.4. Increasing use of telemedicine for diagnostics
- 3.5. Government Regulation
- 3.5.1. Regulatory frameworks for medical devices in Saudi Arabia
- 3.5.2. Compliance with international standards
- 3.5.3. Guidelines for point of care testing
- 3.5.4. Policies promoting local manufacturing of diagnostic devices
- 3.6. SWOT Analysis
- 3.7. Stakeholder Ecosystem
- 3.8. Competition Ecosystem
- 4. Saudi Arabia Point Of Care Infectious Disease Diagnostics Testing Size, Share, Growth Drivers, Trends, Opportunities & – Market Segmentation, 2024
- 4.1. By Product Type (in Value %)
- 4.1.1. Rapid Tests
- 4.1.2. Molecular Diagnostics
- 4.1.3. Serological Tests
- 4.1.4. Others
- 4.2. By End-User (in Value %)
- 4.2.1. Hospitals
- 4.2.2. Diagnostic Laboratories
- 4.2.3. Home Care Settings
- 4.3. By Technology (in Value %)
- 4.3.1. Lateral Flow Assays
- 4.3.2. PCR-based Tests
- 4.4. By Application (in Value %)
- 4.4.1. Infectious Disease Detection
- 4.4.2. Disease Monitoring
- 4.4.3. Others
- 4.5. By Region (in Value %)
- 4.5.1. Central Region
- 4.5.2. Eastern Region
- 4.5.3. Western Region
- 4.5.4. Southern Region
- 4.5.5. Northern Region
- 4.5.6. Others
- 5. Saudi Arabia Point Of Care Infectious Disease Diagnostics Testing Size, Share, Growth Drivers, Trends, Opportunities & – Market Cross Comparison
- 5.1. Detailed Profiles of Major Companies
- 5.1.1. Abbott Laboratories
- 5.1.2. Roche Diagnostics
- 5.1.3. Siemens Healthineers
- 5.1.4. Cepheid
- 5.1.5. Bio-Rad Laboratories
- 5.2. Cross Comparison Parameters
- 5.2.1. No. of Employees
- 5.2.2. Headquarters
- 5.2.3. Inception Year
- 5.2.4. Revenue
- 5.2.5. Product Portfolio
- 6. Saudi Arabia Point Of Care Infectious Disease Diagnostics Testing Size, Share, Growth Drivers, Trends, Opportunities & – Market Regulatory Framework
- 6.1. Medical Device Standards
- 6.2. Compliance Requirements and Audits
- 6.3. Certification Processes
- 7. Saudi Arabia Point Of Care Infectious Disease Diagnostics Testing Size, Share, Growth Drivers, Trends, Opportunities & – Market Future Size (in USD Bn), 2025–2030
- 7.1. Future Market Size Projections
- 7.2. Key Factors Driving Future Market Growth
- 8. Saudi Arabia Point Of Care Infectious Disease Diagnostics Testing Size, Share, Growth Drivers, Trends, Opportunities & – Market Future Segmentation, 2030
- 8.1. By Product Type (in Value %)
- 8.2. By End-User (in Value %)
- 8.3. By Technology (in Value %)
- 8.4. By Application (in Value %)
- 8.5. By Region (in Value %)
- Disclaimer
- Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
